Skip to main content
# Title Department Research Year
881 Enhanced dispersive solid phase extraction assisted by cloud point strategy prior to fluorometric determination of anti-hepatitis C drug velpatasvir in pharmaceutical tablets and body fluids Department of Pharmaceutical Analytical Chemistry 2018
882 A rapid Fourier transform infrared spectroscopic method for analysis of certain proton pump inhibitors in binary and ternary mixtures Department of Pharmaceutical Analytical Chemistry 2018
883 Novel N-Substituted 5-aminosalicylamides as Dual Inhibitors of Cyclooxygenase and 5-Lipoxygenase Enzymes: Synthesis, Biological Evaluation and Docking Study 2018
884 Simultaneous quantitation of two direct acting hepatitis C antivirals (sofosbuvir and daclatasvir) by an HPLC-UV method designated for their pharmacokinetic study in rabbits Department of Pharmaceutical Analytical Chemistry 2018
885 Glibenclamide Mini-tablets with an Enhanced Pharmacokinetic and Pharmacodynamic Performance Department of Industrial Pharmacy 2018
886 Utility of Ionic Liquid-based Surfactant in Enhancement of Oxidation Peak Signal of Atorvastatin at Pencil Graphite Electrode Department of Pharmaceutical Analytical Chemistry 2018
887 Mucoadhesive Tablets for the Vaginal Delivery of Progesterone: In Vitro Evaluation and Pharmacokinetics/Pharmacodynamics in Female Rabbits Department of Pharmaceutics 2018
888 Self-Emulsifying Drug-Delivery Systems Modulate P-Glycoprotein Activity: Role of Excipients and Formulation Aspects Department of Pharmaceutics 2018
889 Fluorimetric determination of febuxostat in dosage forms and in real human plasma via Förster resonance energy transfer‏ Department of Pharmaceutical Analytical Chemistry 2018
890 Ultrasensitive Spectrofluorimetric Method for Rapid Determination of Daclatasvir and Ledipasvir in Human Plasma and Pharmaceutical Formulations Department of Pharmaceutical Analytical Chemistry 2018